Germany: Aventis to develop with Coley
Article Abstract:
Aventis Pharma and US Coley Pharmaceutical Group Inc will join forces in the field of product development and licensing. Through this deal, Aventis gets the worldwide exclusive rights for the development of asthma and allergic rhinitis drugs which use the new immunmodulators (CpG) developed by Coley.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
GERMANY: NEW TEST FOR THROMBOSIS THERAPY MONITORING
Article Abstract:
By the end of 2001 a German Jena-based company called Haemosys GmbH is to launch PADA test, which allows the monitoring of thrombosis therapy. The test that controls the adhesion of platelets is said to be the first such product in the market.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
User Contributions:
Comment about this article or add new information about this topic: